Products
XY Leap™ Omics Platform
XY Leap™ is an advanced Clinical Decision Support Software solution approved by the New Zealand Medicines and Medical Devices Safety Authority.
The clinical utility of the XY Leap™ Omics Platform is second to none. One test informs individualized medicine for life. The XY Analytics™ engine at the core of the platform analyses an individual’s toxicogenomic, nutrigenomic, exercise genomic, and clinical genetic data to deliver:
DNA-guided precision therapeutics for all medical and surgical subspecialties' at point-of-care.
Evidence-based precise, predictive, preventive, participatory, and personalized [P5] medicine.
XY Leap™ provides personalized DNA-guided therapeutics to reduce the harm from environmental toxins including endocrine disruptors and forever chemicals from microplastic leachate, air pollutants, food additives, pesticides, and herbicides.
Longevity Omics AI Agent
The Longevity Omics AI Agent is a specialised Large Language Model (LLM) fine-tuned with clinical toxicogenomics, nutrigenomics, exercise genomics, and clinical genetics. It enhances the clinical value of preventive omics by interpreting complex multi-omic data and delivering precise, personalised insights.
The AI supports clinicians by identifying drivers of biological aging, predicting health risks, and guiding targeted lifestyle and therapeutic interventions tailored to each patient’s genomic profile.